Literature DB >> 31646469

Reducing motion-correction-induced variability in 82rubidium myocardial blood-flow quantification.

Venkatesh L Murthy1, Edward P Ficaro2,1, Alexis Poitrasson-Rivière3, Jonathan B Moody2, Tomoe Hagio2, Richard L Weinberg1, James R Corbett4.   

Abstract

BACKGROUND: Clinical use of myocardial blood flow (MBF) and flow reserve (MFR) is increasing. Motion correction is necessary to obtain accurate results but can introduce variability when performed manually. We sought to reduce that variability with an automated motion-correction algorithm.
METHODS: A blinded randomized controlled trial of two technologists was performed on the motion correction of 100 dynamic 82Rb patient studies comparing manual motion correction with manual review and adjustment of automated motion correction. Inter-rater variability between technologists for MBF and MFR was the primary outcome with comparison made by analysis of the limits of agreement. Processing time was the secondary outcome.
RESULTS: Limits of agreements between the two technologists decreased significantly for both MBF and MFR, going from [- 0.22, 0.22] mL/min/g and [- 0.31, 0.36] to [- 0.12, 0.15] mL/min/g and [- 0.15, 0.18], respectively (both P < .002). In addition, the average time spent on motion correcting decreased by 1 min per study from 5:21 to 4:21 min (P = .001).
CONCLUSIONS: In this randomized controlled trial, the use of automated motion correction significantly decreased inter-user variability and reduced processing time.

Entities:  

Keywords:  Image analysis; Myocardial blood flow; PET

Mesh:

Substances:

Year:  2019        PMID: 31646469      PMCID: PMC7176539          DOI: 10.1007/s12350-019-01911-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  11 in total

1.  Automated dynamic motion correction using normalized gradient fields for 82rubidium PET myocardial blood flow quantification.

Authors:  Benjamin C Lee; Jonathan B Moody; Alexis Poitrasson-Rivière; Amanda C Melvin; Richard L Weinberg; James R Corbett; Venkatesh L Murthy; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2018-11-07       Impact factor: 5.952

2.  Mixed models for assessing correlation in the presence of replication.

Authors:  Anthony Hamlett; Louise Ryan; Paulina Serrano-Trespalacios; Russ Wolfinger
Journal:  J Air Waste Manag Assoc       Date:  2003-04       Impact factor: 2.235

3.  Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 pet and a highly automated analysis program.

Authors:  Ran Klein; Jennifer M Renaud; Maria C Ziadi; Stephanie L Thorn; Andy Adler; Rob S Beanlands; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2010-04-13       Impact factor: 5.952

4.  Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.

Authors:  Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Mariya Gaber; Gilda Di Carli; Ron Blankstein; Sharmila Dorbala; Arkadiusz Sitek; Michael J Pencina; Marcelo F Di Carli
Journal:  Circulation       Date:  2011-10-17       Impact factor: 29.690

5.  Corridor4DM: the Michigan method for quantitative nuclear cardiology.

Authors:  Edward P Ficaro; Benjamin C Lee; James N Kritzman; James R Corbett
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

6.  Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.

Authors:  Maria C Ziadi; Robert A Dekemp; Kathryn A Williams; Ann Guo; Benjamin J W Chow; Jennifer M Renaud; Terrence D Ruddy; Niroshi Sarveswaran; Rebecca E Tee; Rob S B Beanlands
Journal:  J Am Coll Cardiol       Date:  2011-08-09       Impact factor: 24.094

7.  Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography.

Authors:  Masanao Naya; Venkatesh L Murthy; Viviany R Taqueti; Courtney R Foster; Josh Klein; Mariya Garber; Sharmila Dorbala; Jon Hainer; Ron Blankstein; Frederick Resnic; Marcelo F Di Carli
Journal:  J Nucl Med       Date:  2014-01-09       Impact factor: 10.057

8.  Short-term repeatability of resting myocardial blood flow measurements using rubidium-82 PET imaging.

Authors:  Matthew Efseaff; Ran Klein; Maria C Ziadi; Rob S Beanlands; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2012-07-24       Impact factor: 5.952

9.  Repeatability of rest and hyperemic myocardial blood flow measurements with 82Rb dynamic PET.

Authors:  Osamu Manabe; Keiichiro Yoshinaga; Chietsugu Katoh; Masanao Naya; Robert A deKemp; Nagara Tamaki
Journal:  J Nucl Med       Date:  2008-12-17       Impact factor: 10.057

View more
  5 in total

1.  Multiparametric Cardiac 18F-FDG PET in Humans: Kinetic Model Selection and Identifiability Analysis.

Authors:  Yang Zuo; Ramsey D Badawi; Cameron C Foster; Thomas Smith; Javier E López; Guobao Wang
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2020-10-15

2.  Deriving myocardial blood flow reserve from perfusion datasets: Dream or reality?

Authors:  Alexis Poitrasson-Rivière; Venkatesh L Murthy
Journal:  J Nucl Cardiol       Date:  2021-01-13       Impact factor: 5.952

Review 3.  Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications.

Authors:  Piotr J Slomka; Jonathan B Moody; Robert J H Miller; Jennifer M Renaud; Edward P Ficaro; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2020-10-16       Impact factor: 5.952

Review 4.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2021-06-08       Impact factor: 5.952

5.  Dynamic cardiac PET motion correction using 3D normalized gradient fields in patients and phantom simulations.

Authors:  Jonathon A Nye; Marina Piccinelli; Doyeon Hwang; Charles David Cooke; Jin Chul Paeng; Joo Myung Lee; Sang-Geon Cho; Russell Folks; Hee-Seung Bom; Bon-Kwon Koo; Ernest V Garcia
Journal:  Med Phys       Date:  2021-07-20       Impact factor: 4.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.